Literature DB >> 29339351

High-Target Versus Low-Target Blood Pressure Management During Cardiopulmonary Bypass to Prevent Cerebral Injury in Cardiac Surgery Patients: A Randomized Controlled Trial.

Anne G Vedel1, Frederik Holmgaard2, Lars S Rasmussen3, Annika Langkilde4, Olaf B Paulson5, Theis Lange6, Carsten Thomsen4, Peter Skov Olsen7, Hanne Berg Ravn2, Jens C Nilsson2.   

Abstract

BACKGROUND: Cerebral injury is an important complication after cardiac surgery with the use of cardiopulmonary bypass. The rate of overt stroke after cardiac surgery is 1% to 2%, whereas silent strokes, detected by diffusion-weighted magnetic resonance imaging, are found in up to 50% of patients. It is unclear whether a higher versus a lower blood pressure during cardiopulmonary bypass reduces cerebral infarction in these patients.
METHODS: In a patient- and assessor-blinded randomized trial, we allocated patients to a higher (70-80 mm Hg) or lower (40-50 mm Hg) target for mean arterial pressure by the titration of norepinephrine during cardiopulmonary bypass. Pump flow was fixed at 2.4 L·min-1·m-2. The primary outcome was the total volume of new ischemic cerebral lesions (summed in millimeters cubed), expressed as the difference between diffusion-weighted imaging conducted preoperatively and again postoperatively between days 3 and 6. Secondary outcomes included diffusion-weighted imaging-evaluated total number of new ischemic lesions.
RESULTS: Among the 197 enrolled patients, mean (SD) age was 65.0 (10.7) years in the low-target group (n=99) and 69.4 (8.9) years in the high-target group (n=98). Procedural risk scores were comparable between groups. Overall, diffusion-weighted imaging revealed new cerebral lesions in 52.8% of patients in the low-target group versus 55.7% in the high-target group (P=0.76). The primary outcome of volume of new cerebral lesions was comparable between groups, 25 mm3 (interquartile range, 0-118 mm3; range, 0-25 261 mm3) in the low-target group versus 29 mm3 (interquartile range, 0-143 mm3; range, 0-22 116 mm3) in the high-target group (median difference estimate, 0; 95% confidence interval, -25 to 0.028; P=0.99), as was the secondary outcome of number of new lesions (1 [interquartile range, 0-2; range, 0-24] versus 1 [interquartile range, 0-2; range, 0-29] respectively; median difference estimate, 0; 95% confidence interval, 0-0; P=0.71). No significant difference was observed in frequency of severe adverse events.
CONCLUSIONS: Among patients undergoing on-pump cardiac surgery, targeting a higher versus a lower mean arterial pressure during cardiopulmonary bypass did not seem to affect the volume or number of new cerebral infarcts. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02185885.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  blood pressure; cardiopulmonary bypass; cerebral infarction; coronary artery bypass; heart valves; neuroprotection

Mesh:

Substances:

Year:  2018        PMID: 29339351     DOI: 10.1161/CIRCULATIONAHA.117.030308

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

1.  Poster Viewing Sessions PB01-B01 to PB03-V09.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

2.  The association between postoperative cognitive dysfunction and cerebral oximetry during cardiac surgery: a secondary analysis of a randomised trial.

Authors:  Frederik Holmgaard; Anne G Vedel; Lars S Rasmussen; Olaf B Paulson; Jens C Nilsson; Hanne B Ravn
Journal:  Br J Anaesth       Date:  2019-05-17       Impact factor: 9.166

Review 3.  Incidence and Risk Factors for Silent Brain Infarction After On-Pump Cardiac Surgery: A Meta-analysis and Meta-regression of 29 Prospective Cohort Studies.

Authors:  Jingfei Guo; Chenghui Zhou; Liu Yue; Fuxia Yan; Jia Shi
Journal:  Neurocrit Care       Date:  2021-04       Impact factor: 3.210

Review 4.  Vasopressor therapy in critically ill patients with shock.

Authors:  James A Russell
Journal:  Intensive Care Med       Date:  2019-10-23       Impact factor: 17.440

Review 5.  Heterogeneous impact of hypotension on organ perfusion and outcomes: a narrative review.

Authors:  Lingzhong Meng
Journal:  Br J Anaesth       Date:  2021-08-12       Impact factor: 9.166

Review 6.  An Update on Postoperative Cognitive Dysfunction Following Cardiac Surgery.

Authors:  Tony Vu; Julian A Smith
Journal:  Front Psychiatry       Date:  2022-06-15       Impact factor: 5.435

Review 7.  Morbidity and mortality in patients managed with high compared with low blood pressure targets during on-pump cardiac surgery: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Charlotte C McEwen; Takhliq Amir; Yuan Qiu; Jack Young; Kevin Kennedy; Hilary P Grocott; Hessam Kashani; David Mazer; Scott Brudney; Morvarid Kavosh; Eric Jacobsohn; Anne Vedel; Eugene Wang; Richard P Whitlock; Emilie P Belley-Coté; Jessica Spence
Journal:  Can J Anaesth       Date:  2022-01-10       Impact factor: 6.713

8.  Associations between mean arterial pressure during cardiopulmonary bypass and biomarkers of cerebral injury in patients undergoing cardiac surgery: secondary results from a randomized controlled trial.

Authors:  Sebastian Wiberg; Frederik Holmgaard; Kaj Blennow; Jens C Nilsson; Jesper Kjaergaard; Michael Wanscher; Annika R Langkilde; Christian Hassager; Lars S Rasmussen; Henrik Zetterberg; Anne Grønborg Vedel
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-01-22

9.  Current Neurologic Assessment and Neuroprotective Strategies in Cardiac Anesthesia: A Survey to the Membership of the Society of Cardiovascular Anesthesiologists.

Authors:  Martin Krause; Joseph E Morabito; G Burkhard Mackensen; Tjörvi E Perry; Karsten Bartels
Journal:  Anesth Analg       Date:  2020-08       Impact factor: 6.627

10.  The correlation of intraoperative hypotension and postoperative cognitive impairment: a meta-analysis of randomized controlled trials.

Authors:  Xiaojin Feng; Jialing Hu; Fuzhou Hua; Jing Zhang; Lieliang Zhang; Guohai Xu
Journal:  BMC Anesthesiol       Date:  2020-08-05       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.